causal
Pharma Moats Come From Manufacturing Complexity
Pharma now has a moat against generics because manufacturing is hard to copy, as with Vertex's cystic fibrosis drugs, so companies keep cash flow after patent expiry and reinvest it into new patents and therapies.
causalpending
Speaker
Anne-Marie PetersonEvidence Quote
“unlike other drugs in the past, there's a moat for generics, which is the manufacturing. ... even Vertex in their cystic fibrosis business, they've got a process that need lots of generics that try to copy the drug and can't.”
Source
Anne-Marie Peterson - The Capital System - [Invest Like the Best, EP.364]— Invest Like the BestCreated: 11/14/2026, 4:41:01 AM
Your notes
Loading notes...